Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1994 Nov 1;151(9):1289–1290.

Toxic effects of theophylline caused by fluvoxamine.

A M van den Brekel 1, L Harrington 1
PMCID: PMC1337329  PMID: 7954177

Full text

PDF
1289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crewe H. K., Lennard M. S., Tucker G. T., Woods F. R., Haddock R. E. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol. 1992 Sep;34(3):262–265. doi: 10.1111/j.1365-2125.1992.tb04134.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Diot P., Jonville A. P., Gerard F., Bonnelle M., Autret E., Breteau M., Lemarie E., Lavandier M. Possible interaction entre théophylline et fluvoxamine. Therapie. 1991 Mar-Apr;46(2):170–171. [PubMed] [Google Scholar]
  3. Jonkman J. H., Upton R. A. Pharmacokinetic drug interactions with theophylline. Clin Pharmacokinet. 1984 Jul-Aug;9(4):309–334. doi: 10.2165/00003088-198409040-00002. [DOI] [PubMed] [Google Scholar]
  4. Schwartz J., Jauregui L., Lettieri J., Bachmann K. Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum. Antimicrob Agents Chemother. 1988 Jan;32(1):75–77. doi: 10.1128/aac.32.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Sherrill D. L., Lebowitz M. D., Burrows B. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med. 1990 Sep;11(3):375–387. [PubMed] [Google Scholar]
  6. Sperber A. D. Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy. Drug Saf. 1991 Nov-Dec;6(6):460–462. doi: 10.2165/00002018-199106060-00006. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES